What is the current annual EBITDA of GMAB?

As of today, GMAB annual EBITDA is $1.33B

What is 1-year change in GMAB annual EBITDA?

GMAB annual EBITDA is up +23.20% year-over-year

What is 3-year change in GMAB annual EBITDA?

GMAB annual EBITDA is up +42.22% over the past 3 years

How far is GMAB annual EBITDA from its all-time high?

GMAB annual EBITDA is currently at its all-time high

How does GMAB annual EBITDA rank versus sector peers?

GMAB annual EBITDA is higher than 93.92% of companies in Healthcare sector

When is GMAB next annual earnings release?

As of today, the next annual earnings release for GMAB has not been scheduled

What is the current quarterly EBITDA of GMAB?

As of today, GMAB quarterly EBITDA is $432.37M

What is GMAB quarterly EBITDA most recent change?

GMAB quarterly EBITDA was up +69.60% on June 30, 2026

What is 1-year change in GMAB quarterly EBITDA?

GMAB quarterly EBITDA is up +13.46% year-over-year

How far is GMAB quarterly EBITDA from its all-time high?

GMAB quarterly EBITDA is currently -35.00% below its historical high of $665.22M set on June 30, 2020

How does GMAB quarterly EBITDA rank versus sector peers?

GMAB quarterly EBITDA is higher than 94.48% of companies in Healthcare sector

When is GMAB next earnings release?

The next earnings release for GMAB is on November 5, 2026

What is the current TTM EBITDA of GMAB?

As of today, GMAB TTM EBITDA is $1.43B

What is GMAB TTM EBITDA most recent change?

GMAB TTM EBITDA was up +3.73% on June 30, 2026

What is 1-year change in GMAB TTM EBITDA?

GMAB TTM EBITDA is up +14.64% year-over-year

How far is GMAB TTM EBITDA from its all-time high?

GMAB TTM EBITDA is currently at its all-time high

How does GMAB TTM EBITDA rank versus sector peers?

GMAB TTM EBITDA is higher than 93.91% of companies in Healthcare sector

When is GMAB next earnings release?

The next earnings release for GMAB is on November 5, 2026

Genmab A/S (GMAB) EBITDA History & Chart Since 1999

Annual EBITDA

$1.33B$249.56M+23.20%

December 31, 2025

Summary

Current Value: As of today, GMAB annual EBITDA is $1.33B, up +23.20% on December 31, 2025
Historical Performance: GMAB annual EBITDA is up +42.22% over the past 3 years, up +32.11% over the past 5 years
All-Time High Comparison: GMAB annual EBITDA is currently at its all-time high
3-Year Low Comparison: GMAB annual EBITDA is +61.69% above its 3-year low of $819.51M reached on December 31, 2023
Sector Comparison: GMAB annual EBITDA is higher than 93.92% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

GMAB Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$1.33B	+23.2%	+42.2%	+32.1%	+10000.0%
Quarterly EBITDA	Jun 30, 26	$432.37M	+13.5%	–	–	+3684.6%
TTM EBITDA	Jun 30, 26	$1.43B	+14.6%	–	–	+10000.0%
Price	Aug 14, 26	$31.94	+39.0%	-14.4%	-31.4%	+4783.8%
PE Ratio	Aug 14, 26	25.28	+120.4%	-32.7%	-66.8%	–
Annual Revenue	Dec 31, 25	$3.73B	+19.5%	+82.1%	+141.3%	+3512.1%
Annual EPS	Dec 31, 25	$1.54	-12.4%	+32.0%	+39.5%	+1312.3%
	Dec 31, 25	$1.25B	+23.5%	+40.8%	+29.9%	+10000.0%
Annual Net Income	Dec 31, 25	$965.95M	-15.1%	+25.4%	+32.8%	+3897.8%

EBITDA Highs

GMAB Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.33B	Dec 31, 25	at high
5Y	$1.33B	Dec 31, 25	at high
All	$1.33B	Dec 31, 25	at high

EBITDA Lows

GMAB Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$819.51M	Dec 31, 23	+61.7%
5Y	$519.39M	Dec 31, 21	+155.1%
All	-$137.28M	Dec 31, 08	+1065.2%

EBITDA History

Year	Value	Change
2025	$1.33B	+23.2%
2024	$1.08B	+31.2%
2023	$819.51M	-12.0%
2022	$931.68M	+79.4%
2021	$519.39M	-48.2%
2020	$1.00B	+140.9%
2019	$416.30M	+79.2%
2018	$232.36M	+8.4%
2017	$214.40M	+31.9%
2016	$162.51M	+86.5%
2015	$87.12M	+76.4%
2014	$49.38M	+242.8%
2013	$14.40M	+182.2%
2012	-$17.53M	+59.8%

Year	Value	Change
2011	-$43.64M	>-9,900.0%
2010	-$378.00K	+99.5%
2009	-$74.12M	+46.0%
2008	-$137.28M	-75.5%
2007	-$78.24M	-1.4%
2006	-$77.13M	-17.1%
2005	-$65.89M	+0.7%
2004	-$66.38M	-55.2%
2003	-$42.77M	+23.2%
2002	-$55.72M	-117.8%
2001	-$25.59M	-257.7%
2000	-$7.15M	-349.7%
1999	-$1.59M	-

FAQ

What is the current annual EBITDA of GMAB?: As of today, GMAB annual EBITDA is $1.33B
What is 1-year change in GMAB annual EBITDA?: GMAB annual EBITDA is up +23.20% year-over-year
What is 3-year change in GMAB annual EBITDA?: GMAB annual EBITDA is up +42.22% over the past 3 years
How far is GMAB annual EBITDA from its all-time high?: GMAB annual EBITDA is currently at its all-time high
How does GMAB annual EBITDA rank versus sector peers?: GMAB annual EBITDA is higher than 93.92% of companies in Healthcare sector
When is GMAB next annual earnings release?: As of today, the next annual earnings release for GMAB has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$432.37M$177.43M+69.60%

June 30, 2026

Summary

Current Value: As of today, GMAB quarterly EBITDA is $432.37M, up +69.60% on June 30, 2026
Historical Performance: GMAB quarterly EBITDA is up +13.46% year-over-year
All-Time High Comparison: GMAB quarterly EBITDA is currently -35.00% below its historical high of $665.22M set on June 30, 2020
3-Year Low Comparison: GMAB quarterly EBITDA is +111.80% above its 3-year low of $204.14M reached on March 31, 2025
Sector Comparison: GMAB quarterly EBITDA is higher than 94.48% of companies in Healthcare sector

Performance

GMAB Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	$432.37M	+69.6%	+13.5%	–	–
Annual EBITDA	Dec 31, 25	$1.33B	–	+23.2%	+42.2%	+32.1%
TTM EBITDA	Jun 30, 26	$1.43B	+3.7%	+14.6%	–	–
Price	Aug 14, 26	$31.94	+18.7%	+39.0%	-14.4%	-31.4%
PE Ratio	Aug 14, 26	25.28	+24.6%	+120.4%	-32.7%	-66.8%
Quarterly Revenue	Jun 30, 26	$1.15B	+28.3%	+23.0%	+89.4%	+260.8%
Quarterly EPS	Jun 30, 26	$0.49	+488.6%	-11.4%	+65.5%	+552.0%
	Jun 30, 26	$406.42M	+80.0%	+11.4%	+89.5%	+218.5%
Quarterly Net Income	Jun 30, 26	$302.57M	+468.8%	-11.2%	+55.1%	+509.9%

Quarterly EBITDA Highs

GMAB Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$474.87M	Sep 30, 25	-8.9%
3Y	$474.87M	Sep 30, 25	-8.9%
5Y	$474.87M	Sep 30, 25	-8.9%
All	$665.22M	Jun 30, 20	-35.0%

Quarterly EBITDA Lows

GMAB Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$254.94M	Mar 31, 26	+69.6%
3Y	$204.14M	Mar 31, 25	+111.8%
5Y	$204.14M	Mar 31, 25	+111.8%
All	-$59.21M	Dec 1, 08	+830.2%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$432.37M	+69.6%
Mar 2026	$254.94M	-3.4%
Dec 2025	$263.83M	-44.4%
Sep 2025	$474.87M	+24.6%
Jun 2025	$381.09M	+86.7%
Mar 2025	$204.14M	-38.2%
Dec 2024	$330.27M	+0.6%
Sep 2024	$328.36M	+32.0%
Dec 2023	$248.71M	-3.8%
Sep 2023	$258.46M	+79.7%
Dec 2020	$143.84M	+5.5%
Sep 2020	$136.27M	-79.5%
Jun 2020	$665.22M	+5,684.0%
Mar 2020	$11.50M	-96.4%
Dec 2019	$323.55M	+507.3%
Sep 2019	$53.28M	+145.8%
Jun 2019	$21.68M	+848.8%
Mar 2019	-$2.90M	-253.0%
Dec 2012	-$820.10K	+78.4%
Sep 2012	-$3.80M	+45.8%
Jun 2012	-$7.01M	+5.4%
Mar 2012	-$7.41M	+31.0%
Dec 2011	-$10.74M	-4.7%
Sep 2011	-$10.26M	+15.0%
Jun 2011	-$12.06M	-12.3%
Mar 2011	-$10.74M	+28.0%
Dec 2010	-$14.93M	-149.2%
Sep 2010	$30.34M	+303.4%
Jun 2010	-$14.91M	+42.5%
Mar 2010	-$25.92M	-355.8%
Dec 2009	$10.14M	+127.8%
Sep 2009	-$36.44M	+9.5%

Month	Value	Change
Jun 2009	-$40.27M	-173.7%
Mar 2009	-$14.71M	+75.2%
Dec 2008	-$59.21M	-2,571.8%
Sep 2008	-$2.22M	+95.8%
Jun 2008	-$52.86M	-35.8%
Mar 2008	-$38.94M	-59.5%
Dec 2007	-$24.41M	+29.7%
Sep 2007	-$34.72M	-2,011.0%
Jun 2007	-$1.64M	+90.9%
Mar 2007	-$18.08M	+28.6%
Dec 2006	-$25.31M	-12.1%
Sep 2006	-$22.59M	-50.1%
Jun 2006	-$15.05M	-3.6%
Mar 2006	-$14.53M	+8.5%
Dec 2005	-$15.88M	-3.5%
Sep 2005	-$15.33M	+12.2%
Jun 2005	-$17.46M	-1.4%
Mar 2005	-$17.22M	+14.9%
Dec 2004	-$20.23M	-30.4%
Sep 2004	-$15.51M	+5.7%
Jun 2004	-$16.45M	-24.1%
Mar 2004	-$13.26M	+23.3%
Dec 2003	-$17.29M	-23.9%
Sep 2003	-$13.95M	>-9,900.0%
Jun 2003	-$24.90K	+99.8%
Mar 2003	-$11.64M	+45.2%
Dec 2002	-$21.24M	-63.3%
Sep 2002	-$13.00M	-20.7%
Jun 2002	-$10.78M	+4.0%
Mar 2002	-$11.22M	-239.3%
Mar 2001	-$3.31M	-

FAQ

What is the current quarterly EBITDA of GMAB?: As of today, GMAB quarterly EBITDA is $432.37M
What is GMAB quarterly EBITDA most recent change?: GMAB quarterly EBITDA was up +69.60% on June 30, 2026
What is 1-year change in GMAB quarterly EBITDA?: GMAB quarterly EBITDA is up +13.46% year-over-year
How far is GMAB quarterly EBITDA from its all-time high?: GMAB quarterly EBITDA is currently -35.00% below its historical high of $665.22M set on June 30, 2020
How does GMAB quarterly EBITDA rank versus sector peers?: GMAB quarterly EBITDA is higher than 94.48% of companies in Healthcare sector
When is GMAB next earnings release?: The next earnings release for GMAB is on November 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.43B$51.28M+3.73%

June 30, 2026

Summary

Current Value: As of today, GMAB TTM EBITDA is $1.43B, up +3.73% on June 30, 2026
Historical Performance: GMAB TTM EBITDA is up +14.64% year-over-year
All-Time High Comparison: GMAB TTM EBITDA is currently at its all-time high
3-Year Low Comparison: GMAB TTM EBITDA is +451.73% above its 3-year low of $258.46M reached on September 30, 2023
Sector Comparison: GMAB TTM EBITDA is higher than 93.91% of companies in Healthcare sector

Performance

GMAB Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	$1.43B	+3.7%	+14.6%	–	–
Annual EBITDA	Dec 31, 25	$1.33B	–	+23.2%	+42.2%	+32.1%
Quarterly EBITDA	Jun 30, 26	$432.37M	+69.6%	+13.5%	–	–
Price	Aug 14, 26	$31.94	+18.7%	+39.0%	-14.4%	-31.4%
PE Ratio	Aug 14, 26	25.28	+24.6%	+120.4%	-32.7%	-66.8%
TTM Revenue	Jun 30, 26	$4.13B	+5.5%	+21.8%	+80.5%	+251.6%
TTM EPS	Jun 30, 26	$1.26	-4.8%	-37.0%	+27.1%	+106.8%
	Jun 30, 26	$1.33B	+3.2%	+13.0%	+47.8%	+171.5%
TTM Net Income	Jun 30, 26	$785.93M	-4.6%	-38.2%	+20.0%	+94.8%

TTM EBITDA Highs

GMAB TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.43B	Jun 30, 26	at high
3Y	$1.43B	Jun 30, 26	at high
5Y	$1.43B	Jun 30, 26	at high
All	$1.43B	Jun 30, 26	at high

TTM EBITDA Lows

GMAB TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.24B	N/A	+14.6%
3Y	$258.46M	Sep 30, 23	+451.7%
5Y	$258.46M	Sep 30, 23	+451.7%
All	-$153.23M	Dec 1, 08	+1030.7%

TTM EBITDA History

Month	Value	Change
Jun 2026	$1.43B	+3.7%
Mar 2026	$1.37B	+3.8%
Dec 2025	$1.32B	-4.8%
Sep 2025	$1.39B	+11.8%
Jun 2025	$1.24B	+44.2%
Mar 2025	$862.77M	+31.0%
Dec 2024	$658.63M	+14.1%
Sep 2024	$577.08M	+13.8%
Dec 2023	$507.18M	+96.2%
Sep 2023	$258.46M	-73.0%
Dec 2020	$956.83M	-15.8%
Sep 2020	$1.14B	+7.9%
Jun 2020	$1.05B	+157.0%
Mar 2020	$410.01M	+3.6%
Dec 2019	$395.61M	+449.0%
Sep 2019	$72.06M	+283.6%
Jun 2019	$18.78M	+748.8%
Mar 2019	-$2.90M	+84.8%
Dec 2012	-$19.04M	+34.3%
Sep 2012	-$28.96M	+18.2%
Jun 2012	-$35.42M	+12.5%
Mar 2012	-$40.47M	+7.6%
Dec 2011	-$43.80M	+8.7%
Sep 2011	-$47.99M	-548.8%
Jun 2011	-$7.40M	+27.8%
Mar 2011	-$10.25M	+59.7%
Dec 2010	-$25.43M	-6,904.6%
Sep 2010	-$363.00K	+99.5%
Jun 2010	-$67.14M	+27.4%
Mar 2010	-$92.49M	-13.8%
Dec 2009	-$81.29M	+46.0%
Sep 2009	-$150.63M	-29.4%

Month	Value	Change
Jun 2009	-$116.41M	+9.8%
Mar 2009	-$129.00M	+15.8%
Dec 2008	-$153.23M	-29.4%
Sep 2008	-$118.43M	+21.5%
Jun 2008	-$150.94M	-51.4%
Mar 2008	-$99.72M	-26.5%
Dec 2007	-$78.86M	+1.1%
Sep 2007	-$79.76M	-17.9%
Jun 2007	-$67.63M	+16.5%
Mar 2007	-$81.03M	-4.6%
Dec 2006	-$77.49M	-13.9%
Sep 2006	-$68.05M	-11.9%
Jun 2006	-$60.79M	+3.8%
Mar 2006	-$63.20M	+4.1%
Dec 2005	-$65.89M	+6.2%
Sep 2005	-$70.24M	+0.3%
Jun 2005	-$70.42M	-1.5%
Mar 2005	-$69.41M	-6.1%
Dec 2004	-$65.45M	-4.7%
Sep 2004	-$62.51M	-2.6%
Jun 2004	-$60.95M	-36.9%
Mar 2004	-$44.53M	-3.8%
Dec 2003	-$42.92M	+8.4%
Sep 2003	-$46.86M	-2.1%
Jun 2003	-$45.91M	+19.0%
Mar 2003	-$56.66M	-0.7%
Dec 2002	-$56.24M	-60.7%
Sep 2002	-$35.00M	-59.1%
Jun 2002	-$22.00M	-96.0%
Mar 2002	-$11.22M	-239.3%
Mar 2001	-$3.31M	-

FAQ

What is the current TTM EBITDA of GMAB?: As of today, GMAB TTM EBITDA is $1.43B
What is GMAB TTM EBITDA most recent change?: GMAB TTM EBITDA was up +3.73% on June 30, 2026
What is 1-year change in GMAB TTM EBITDA?: GMAB TTM EBITDA is up +14.64% year-over-year
How far is GMAB TTM EBITDA from its all-time high?: GMAB TTM EBITDA is currently at its all-time high
How does GMAB TTM EBITDA rank versus sector peers?: GMAB TTM EBITDA is higher than 93.91% of companies in Healthcare sector
When is GMAB next earnings release?: The next earnings release for GMAB is on November 5, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

GMAB Official Website www.genmab.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434265/000143426526000014/0001434265-26-000014-index.htm
GMAB Profile on Yahoo Finance finance.yahoo.com/quote/GMAB
GMAB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmab